Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Europe’s Airlines Run Low on Fuel - 2Unwind: Four Extraordinary Spa Resorts On the planet
- 3Instructions to Pick the Right Gold Speculation Procedure: Exploring the Market
- 4Canada's Serene Lakeside Mountain Village Is A Breathtaking Oasis For Outdoor Adventure
- 5First SpaceX booster for upgraded Starship fails during test in Texas
- True to life Authenticity d: A Survey of \Certifiable Stories\ Narrative
- Porsche May Kill the Electric Boxster Before It Ever Arrives
- Rick Steves' Newest Guidebook Is A Fresh Perspective On Italy Spilling The Country's Secrets
- Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand.
- 4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- What to know as New York City nurses strike for a 3rd day
- Vote In favor of Your Favored Shimmering Water
- In a first, scientists observe a comet reversing its spin
- How a rare drug made from scientists' blood saves babies from botulism
